Johnson & Johnson reported fourth-quarter sales and profit above Wall Street estimates on Wednesday, driven by strong sales of its cancer treatments.
Related Posts
Watch Fed Chair Powell speak live about the economy and where interest rates go from here
Investors are looking to the Fed chair for hints about the direction of monetary policy after a weaker-than-expected jobs report.
JPMorgan upgrades a unique, AI-related stock, sees more than 20% upside
Shares of this artificial intelligence-powered marketplace may be poised for more upside in the coming months, according to JPMorgan.
Stock futures edge lower ahead of key economic data, threat of fresh tariffs: Live updates
Stocks remain jittery on a mix of inflation worry coupled with concern over how Trump’s plan for tariffs could affect the U.S. economy